Palomino Laboratories (PALX) Invested Capital (2022 - 2025)
Palomino Laboratories recorded quarterly Invested Capital of $8.1 million in Q4 2025, up 10.72% quarter-over-quarter from $7.3 million in Q3 2025, and up 44335.15% year-over-year from N/an in Q4 2024.
Palomino Laboratories' Invested Capital history runs 4 years deep, the most recent figure standing at $8.1 million for Q4 2025.
- In Q4 2025, Invested Capital rose 44335.15% year-over-year to $8.1 million; the TTM figure through Dec 2025 stood at $8.1 million (up 44335.15% YoY), while the FY2025 annual figure was $8.1 million, up 44335.15% from the prior year.
- Invested Capital came in at $8.1 million for Q4 2025 at Palomino Laboratories, up from $7.3 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $8.1 million in Q4 2025 to a low of -$991653.0 in Q1 2025.
- A 4-year average of $1.1 million and a median of -$18306.0 in 2023 frame the typical range for Invested Capital.
- On a YoY basis, Invested Capital climbed as much as 87763.29% in 2025 and fell as far as 42008.41% in 2025.
- Palomino Laboratories' Invested Capital stood at -$27804.0 in 2022, then jumped by 34.16% to -$18306.0 in 2023, then changed by 0.0% to -$18306.0 in 2024, then soared by 44335.15% to $8.1 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $8.1 million, $7.3 million, and -$447236.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.10 Mn |
| Sep 30, 2025 | 7.31 Mn |
| Jun 30, 2025 | -447,236.00 |
| Mar 31, 2025 | -991,653.00 |
| Dec 31, 2024 | -18,306.00 |
| Sep 30, 2024 | -8,343.00 |
| Jun 30, 2024 | -2,009.00 |
| Mar 31, 2024 | -2,355.00 |
| Dec 31, 2023 | -2,108.00 |
| Sep 30, 2023 | -78,667.00 |
| Jun 30, 2023 | -35,804.00 |
| Mar 31, 2023 | -31,554.00 |
| Dec 31, 2022 | -27,804.00 |